Compare Agilent Technologies Inc (A) vs Nerdwallet Inc (NRDS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs Nerdwallet Inc — how do they compare? Agilent Technologies Inc trades at $130.3 (market cap $37.04B), while Nerdwallet Inc trades at $9.52 (market cap $625.42M). The key difference: Agilent Technologies Inc is far larger — about 59.2× Nerdwallet Inc's market cap, and Agilent Technologies Inc pays a 0.78% dividend while Nerdwallet Inc pays none. Which is the better fit depends on your goals.
| A | NRDS | |
|---|---|---|
Market Cap | $37.04B | $625.42M |
Sector | Health | Financials |
52-Week High | $157.20 | $15.93 |
52-Week Low | $110.24 | $7.58 |
Enterprise Value | $38.59B | $539.72M |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
NRDS trades at $9.50, up 0.32% today, with a bullish technical signal from moving averages but overbought short-term RSI readings. The company shows strong fundamental improvement, with revenue growing from $539M in 2022 to $837M in 2025 and net income turning positive to $48.7M. Recent quarters have consistently beaten EPS estimates, and analyst consensus is a Buy with a $12.75 target, implying 34% upside. Positive news highlights the company's pivot to higher-margin transactions and resilience amid search headwinds.
The outlook is positive given strong earnings beats, robust cash flow, and attractive valuation multiples like a P/E of 10.19. Key risks include reliance on search traffic, competitive pressures, and projected negative net cash flow in 2026. Institutional sentiment is bullish, but investors should monitor execution on growth initiatives and macroeconomic impacts on consumer finance behavior.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Nerdwallet Inc
Nerdwallet Inc is a free tool to find you the best credit cards, cd rates, savings, checking accounts, scholarships, healthcare and airlines.
Read more on NRDS →
